We are a clinical stage biotechnology company developing novel immune therapeutics for the prevention, treatment and mitigation of bacterial, fungal, and parasitic infections that express the antigenic target poly N-acetyl glucosamine (PNAG).
$5.00 - $5.00
October 5, 2022
FORDHAM FINANCIAL MANAGEMENT, INC.
This offering is orderable
Place an order
To view the prospectus for Alopexx, Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277